Cyclic bisbibenzyls induce growth arrest and apoptosis of human prostate cancer PC3 cells

Acta Pharmacologica Sinica

Volumn 31, Issue 5, 2010, Pages 609-615

  Xu, Ai Hui ^a   Hu, Zhi Min ^a   Qu, Jian Bo ^a   Liu, Shang Ming ^a   Syed, Ali Kazim Abbas ^a   Yuan, Hui Qing ^a   Lou, Hong Xiang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Cyclic bisbibenzyls; Liverworts; PC3 cells; Poly(ADP ribose) polymerase; Prostate carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; MARCHANTIN M; NATURAL PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PAKYONOL; PLAGIOCHIN E; PROTEIN BAX; PROTEIN BCL 2; RICCARDIN C; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; GROWTH DISORDER; HUMAN; HUMAN CELL; IC 50; LIVERWORT; PROSTATE CANCER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIBENZYLS; CASPASE 3; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PLANT EXTRACTS; PROSTATIC NEOPLASMS;

EID: 77952062598     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.37     Document Type: Article

References (26)

1. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev 2001;20:225-43.
2. Lee KH. Anticancer drug design based on plant-derived natural products. J Biomed Sci 1999;6:236-50.
3. Kucuk O. Chemoprevention of prostate cancer. Cancer Metastasis Rev 2002;21:111-24.
4. Barnes S. Role of phytochemicals in prevention and treatment of prostate cancer. Epidemiol Rev 2001;23:102-5.
5. Singh RP, Dhanalakshmi S, Agarwal R. Phytochemicals as cell cycle modulators: a less toxic approach in halting human cancers. Cell Cycle 2002;1:156-61.
6. Asakawa Y, Toyota M, Taira Z, Takemoto T, Kido M. Riccardin A and Riccardin B, two novel cyclic bibenzyls possessing cytotoxicity from the liverwort Riccardia multifida (L.) S. Gray. J Org Chem 1983;48:2164-7.
7. Scher JM, Burgess EJ, Lorimer SD, Perry NB. A cytotoxic sesquiterpene and unprecedented sesquiterpenebisbibenzyl compounds from the liverwort Schistochila glaucescens. Tetrahedron 2002;58:7875-82.
8. Nagashima F, Momosaki S, Watanabe Y, Toyota M, Huneck S, Asakawa Y. Terpenoids and aromatic compounds from six liverworts. Phytochemistry 1996;41:207-11.
9. Qu JB, Xie CF, Guo HF, Yu WT, Lou HX. Antifungal dibenzofuran bis (bibenzyl) s from the liverwort Asterella angusta. Phytochemistry 2007;68:1767-74.
10. Xie CF, Qu JB, Wu XZ, Liu N, Ji M, Lou HX. Antifungal macrocyclic bis (bibenzyls) from the Chinese liverwort Ptagiochasm intermedlum L. Nat Prod Res 2010; Feb. 23:1-6. [Epub ahead of print].
11. Niu C, Qu JB, Lou HX. Antifungal bis[bibenzyls] from the Chinese liverwort Marchantia polymorpha L. Chem Biodivers 2006;3:34-40.
12. Wang FQ, Lou HX. Chemical studies on the constituents of Plagiochasm intermedium L. Acta Pharmacol Sin 2000;35:587-91.
13. Baek SH, Phipps RK, Perry NB. Antimicrobial chlorinated bibenzyls from the liverwort Riccardia marginata. J Nat Prod 2004;67:718-20.
14. Scher JM, Speakman JB, Zapp J, Becker H. Bioactivity guided isolation of antifungal compounds from the liverwort Bazzania trilobata (L.) S. F. Gray. Phytochemistry 2004;65:2583-8.
15. Kodama M, Shiobara Y, Sumitomo H, Matsumura K, Tsukamoto M, Harada C. Total syntheses of marchantin A and riccardin B, cytotoxic bis (bibenzyls) from liverworts. J Org Chem 1988;53:72-7.
16. Shi YQ, Zhu CJ, Yuan HQ, Li BQ, Gao J, Qu XJ, et al. Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Lett 2008;276:160-1
17. Shi YQ, Liao YX, Qu XJ, Yuan HQ, Li S, Qu JB, et al. Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells. Cancer Lett 2008;262:173-82.
18. Shi YQ, Qu XJ, Liao YX, Xie CF, Cheng YN, Li S, et al. Reversal effect of a macrocyclic bisbibenzyl plagiochin e on multidrug resistance in adriamycin-resistant K562/A02 cells. Eur J Pharmacol 2008;584:66-71.
19. Asakawa Y, Bors W, Franck U, Michel C, Muller-Jakic B, Nenninger A, et al. Effect of marchantins and related compounds on 5-lipoxygenase and cyclooxygenase and their antioxidant properties: a structure-activity relationship study. Phytomedicine 1995;2:113-7.
20. Yuan HQ, Kong F, Wang XL, Young C, Hu XY, Lou HX. Inhibitory effect of acetyl-11-keto-β-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells. Biochem Pharmacol 2008;75:2112-21.
21. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 2002;376:37-43.
22. Asakawa Y. Biologically active substances found in Hepaticase. Stud Nat Prod Chem 1988;2:277-92.
23. Asakawa Y. Recent advances in phytochemistry of bryophytesacetogenins, terpenoids and bis (bibenzyl) s from selected Japanese, Taiwanese, New Zealand, Argentinean and European liverworts. Phytochemistry 2001;56:297-312.
24. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45.
25. Zegarra-Moro OL, Schmidt LJ, Huang HJ, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgenrefractory prostate cancer cells. Cancer Res 2002;62:1008-13.
26. Liao XB, Tang SQ, Thrasher JB, Griebling TL, Li B. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 2005;4:505-15.